This clinical trial is focused on patients who need a type of shoulder surgery called arthroscopic shoulder surgery. The study is investigating the effects of a medication called tranexamic acid, which is given through an injection into a vein during the surgery. Tranexamic acid is being studied to see if it can help reduce pain after the surgery.
The purpose of the study is to evaluate whether using tranexamic acid can decrease the need for pain relief medications, like morphine, in the first 24 hours after surgery. During the study, some patients will receive tranexamic acid, while others will receive a different solution called sodium chloride, which is often used in medical settings as a standard fluid. This will help researchers compare the effects of tranexamic acid with those of sodium chloride.
Participants in the study will have their shoulder pain assessed at different times after the surgery, including 24 hours and 7 days later. They will also be asked about their satisfaction with the anesthesia experience and the functionality of their shoulder 30 days after the surgery. The study will also monitor any side effects that occur during the trial. The goal is to gather information that could improve pain management for patients undergoing shoulder surgery in the future.



France